- Academic research groups or early start-ups working on drug discovery projects for the treatment of viral infections in immunocompromised patients
- BK virus
- Other viruses
Often, it is not the lack of groundbreaking ideas that prevents the development of novel, innovative anti-infective drugs. Rather, a lack of funding, development and business experience limits resources for start-ups and scientific groups, discouraging the development of new therapeutic options. AiCuris strongly believes that there is a need to encourage the development of more early projects. Therefore, we are constantly searching for novel technologies and creative approaches to develop more effective treatments against infectious diseases with high medical needs.
For additional questions and submission of applications please contact us